Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype.

Neurobiology of aging - 1 Dec 2008

Haan Mary N, Aiello Allison E, West Nancy A, Jagust William J

Abstract excerpt

BACKGROUND: Those with an Apolipoprotein APOE4 allele (APOE4) have lower C-reactive protein (CRP) than those without APOE4. Whether APOE4 modifies the effects of CRP on rate of all cause dementia, cognitive impairment or Alzheimer's disease (AD) is not established. METHODS: All cause dementia and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein E4
Share to C-Reactive Protein
Share to Cognition Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Comorbidity

Share to Dementia

Share to Incidence

Share to Risk Assessment

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 17540481
DOI: 10.1016/j.neurobiolaging.2007.04.020
PMCID: PMC2593150

Genes

CRP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17540481-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype.PMID 17540481Read ↗

High levels of serum C-reactive protein are associated with greater risk of all-cause mortality, but not dementia, in the oldest-old: results from The 90+ Study.Semantic proximity Read ↗

Impact of C-Reactive Protein on Cognition and Alzheimer Disease Biomarkers in Homozygous APOE ɛ4 CarriersSemantic proximity Read ↗

Decreased plasma C‐reactive protein levels in APOE ε4 allele carriersSemantic proximity Read ↗

Leading determinants of incident dementia among individuals with and without the apolipoprotein E ε4 genotype: a retrospective cohort study.Semantic proximity Read ↗

Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohortSemantic proximity Read ↗

The role of dementia in the association between APOE4 and all-cause mortality: pooled analyses of two population-based cohort studies.Semantic proximity Read ↗

Apolipoprotein E e4 allele affects risk of hyperhomocysteinemia in the elderly.Semantic proximity Read ↗

Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study.Semantic proximity Read ↗

The Effect of the APOE ε2ε4 Genotype on the Development of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) in Non-Latino Whites.Semantic proximity Read ↗

APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts.Semantic proximity Read ↗

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.Semantic proximity Read ↗

Serum apolipoprotein E is associated with long-term risk of Alzheimer's disease: The Rotterdam Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.